Division of Gastroenterology Hepatology and Nutrition

Sara Horst, MD, MPH
October 13, 2022

Horst takes on new roles in advancing digital health

Sara Horst, MD, MPH, has been named associate vice chair for Digital Health Operations for Vanderbilt’s Department of Medicine and assistant chief for Clinical Informatics for the Division of Gastroenterology, Hepatology and Nutrition.

By Leigh MacMillan
A Vanderbilt study shows that reducing consumption of simple sugars helped improve gastroesophageal reflux disease.
October 6, 2022

Study finds that reducing intake of simple sugars improves GERD

A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.

By Leigh MacMillan
September 22, 2022

Colon cancer researchers awarded NCI grant for study of early lesions

Vanderbilt researchers are studying precancerous lesions and early cancers in the colon, with the goal of developing new ways to prevent colorectal cancer, the nation’s second leading cancer killer.

By Sarah E. Glass
July 28, 2022

Video vital for telehealth visits

Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.

By Bill Snyder
Sara Horst, MD, MPH
June 16, 2022

Horst, Patterson receive Physician Builder Awards

Sara Horst, MD, MPH, associate professor of Medicine, and Barron Patterson, MD, associate professor of Pediatrics, have received 2022 Physician Builder Awards.

By Paul Govern
x-ray of stomach
April 7, 2022

New prognosis predictor and target for gastric cancer

The protein CGA — a subunit of glycoprotein hormones — is a biomarker that predicts chemoresistance in gastric cancer and could be targeted along with EGFR to restore chemosensitivity.

By Sarah E. Glass
March 30, 2022

Horst named medical director for telehealth at VUMC

Sara Horst, MD, MPH, has been named the new medical director for Telehealth Ambulatory Services for Vanderbilt University Medical Center.
By Jill Clendening
December 14, 2021

Study sets framework for precision surveillance of colorectal cancer

Vanderbilt research has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine.
By Tom Wilemon
December 10, 2021

“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.
By Bill Snyder
September 21, 2021

The role of polarity in early cancer

Mutations in the protein epiregulin, an EGF receptor ligand, affect larger epithelial cell reorganization and may contribute to early cancer development, Vanderbilt researchers discovered.
By VUMC News and Communications
August 24, 2021

New Clinician Spotlight: Neil Price

Neil Price, MD, assistant professor of Clinical Medicine, joined Vanderbilt University Medical Center recently and specializes in gastroenterology.
By VUMC News and Communications
February 4, 2021

Potential biomarker for IBD severity, cancer risk identified

A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.
By Leigh MacMillan
October 15, 2020

Possible COVID-19 “decoy”

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.
By Bill Snyder
1 2 3 4 … 7